{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q15063",
      "entity_text" : "PN",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pfam:PF02512",
      "entity_text" : "UK",
      "entity_type" : "family"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "XREF_BIBR However, PN is of interest in this review because previous studies have indicated that current UK licensed amino-acid (AA) formulations commonly cause hypoargininemia in PN dependent neonates.",
  "reading_complete" : "2020-08-02T08:32:06Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T08:30:09Z",
  "trigger" : "cause",
  "evidence" : [ "UK-licensed amino-acid (AA) formulations commonly cause hypoargininemia in PN" ],
  "pmc_id" : "6888765",
  "score" : 0
}